Friday, February 28, 2020
PHARM401 projects on prevalence of off-label use for coagulation factors in hemophilia
PharmD students Milena Ljumovic and Trisha Manucha present their PHARM401 research on the prevalence of off-label use for coagulation factors VIII and IX based on data from the Web-Accessible Population Pharmacokinetics Service – Hemophilia (WAPPS-Hemo.org). The results indicate that off-label use is higher for FIX (approx. 60%) than for FVIII (35%).